Display Settings:

Format

Send to:

Choose Destination

    Biochem Biophys Res Commun. 1994 Aug 30;203(1):141-8.

    Human vasoactive intestinal peptide1 receptors expressed by stable transfectants couple to two distinct signaling pathways.

    Sreedharan SP, Patel DR, Xia M, Ichikawa S, Goetzl EJ.

    Department of Medicine, University of California, San Francisco 94143-0711.

    Vasoactive intestinal peptide (VIP) is a potent neuropeptide mediator of central and peripheral nervous system function. A human VIP1 receptor (HVR) cDNA clone was previously obtained from HT29 intestinal epithelial cells and lung tissue. Stably-transfected human embryonic kidney 293 cells and chinese hamster ovary (CHO) cells expressing about 10(6) HVRs per cell that bind [125I]VIP with a Kd of 0.2-0.8 nM, and specifically recognized by anti-HVR antibodies, were established and characterized. VIP induced increases in intracellular cAMP levels ([cAMP]i) dose-dependently with an EC50 of 0.2 nM in 293 and CHO stable transfectants and concurrently evoked dose-dependent increases in intracellular calcium concentrations ([Ca2+]i), as determined by fluorescence-dye spectroscopy. Untransfected 293 and CHO cells showed minimal binding or intracellular effects of VIP; however, native VIP1 receptors of HT29 cells also increased [cAMP]i and [Ca2+]i in dose-dependent responses to VIP. Thus recombinant and native human VIP1 receptors both couple to two distinct signal transduction pathways within a single cell type.

    PMID: 8074647 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read